Donald Shum


+1 212 479 6529

Donald Shum’s practice focuses on the representation of both issuers and investment banks on a variety of capital markets and corporate transactions, including initial public offerings and other equity offerings, high-yield, investment-grade and convertible debt offerings. Donald also regularly counsels public companies with respect to general corporate matters, including SEC reporting and corporate governance.

Download full bio


  • Verrica Pharmaceuticals – $86 Million IPO 

  • MeiraGTx – $75 Million IPO 

  • LogicBio Therapeutics – $80.5 Million IPO 

  • Karuna Therapeutics $103 million IPO 

  • Precision BioSciences $145 Million IPO 


  • University of Virginia School of Law
    JD, summa cum laude, Order of the Coif, 2013

  • Washington University in St. Louis
    BSBA, Finance, Accounting and International Business
    summa cum laude, 2008

Admissions & Credentials

New York

Media & Insight


+1 212 479 6529 office

55 Hudson Yards
New York, NY 10001-2157